Dr. Ahmed Lawan, an assistant professor in the College of Science at The University of Alabama in Huntsville (UAH), a part of ...

BERLIN, Sept 24 (Reuters) - Mercedes-Benz (MBGn.DE), opens new tab announced changes to its top management on Wednesday, replacing chief technology officer Markus Schaefer with head of production ...

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, ...

A pill version of semaglutide — the active ingredient in Ozempic and Wegovy — helped people lose more than 13% of their body weight in a late-stage trial, pharmaceutical giant Novo Nordisk announced ...

Federal Government has said it will begin production of insulin in Nigeria as part of efforts to reduce dependence on imported drugs and improve access to affordable diabetes treatment. Minister of ...

When someone is diagnosed with diabetes, it’s usually pretty simple which one they have — Type 1 or Type 2. The rate of diabetes has grown worldwide, having surpassed 800 million people a year ago. By ...

After growing up without reliable power at home, Iwnetim Abate is working to develop a steady supply of sustainable energy. Iwnetim Abate is one of MIT Technology Review’s 2025 Innovators Under 35.

BYD is the largest new energy vehicle manufacturer in China in terms of sales volume. Targeting the mass market, it produces both battery electric vehicles and plug-in hybrid vehicles, or PHEVs. BYD ...

A new drug has shown promise as a type 2 diabetes and weight loss treatment—potentially offering an new rival to drugs like Ozempic. Ecnoglutide—a new once-weekly GLP-1 receptor agonist injection ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish pharmaceutical company has enacted a hiring freeze—the latest sign of a sinking ...